Quantification of myocardial hemorrhage using T2* cardiovascular magnetic resonance at 1.5T with ex-vivo validation
dc.contributor.author | Chen, Yinyin | |
dc.contributor.author | Ren, Daoyuan | |
dc.contributor.author | Guan, Xingmin | |
dc.contributor.author | Yang, Hsin‑Jung | |
dc.contributor.author | Liu, Ting | |
dc.contributor.author | Tang, Richard | |
dc.contributor.author | Ho, Hao | |
dc.contributor.author | Jin, Hang | |
dc.contributor.author | Zeng, Mengsu | |
dc.contributor.author | Dharmakumar, Rohan | |
dc.contributor.department | Radiology and Imaging Sciences, School of Medicine | |
dc.date.accessioned | 2025-01-21T13:38:46Z | |
dc.date.available | 2025-01-21T13:38:46Z | |
dc.date.issued | 2021-09-30 | |
dc.description.abstract | Background: T2* cardiovascular magnetic resonance (CMR) is commonly used in the diagnosis of intramyocardial hemorrhage (IMH). For quantifying IMH with T2* CMR, despite the lack of consensus studies, two different methods [subject-specific T2* (ssT2*) and absolute T2* thresholding (aT2* < 20 ms)] are interchangeably used. We examined whether these approaches yield equivalent information. Methods: ST elevation myocardial infarction (STEMI) patients (n = 70) were prospectively recruited for CMR at 4-7 days post revascularization and for 6-month follow up (n = 43). Canines studies were performed for validation purposes, where animals (n = 20) were subject to reperfused myocardial infarction (MI) and those surviving the MI (n = 16) underwent CMR at 7 days and 8 weeks and then euthanized. Both in patients and animals, T2* of IMH and volume of IMH were determined using ssT2* and aT2* < 20 ms. In animals, ex-vivo T2* CMR and mass spectrometry for iron concentration ([Fe]Hemo) were determined on excised myocardial sections. T2* values based on ssT2* and absolute T2* threshold approaches were independently regressed against [Fe]Hemo and compared. A range of T2* cut-offs were tested to determine the optimized conditions relative to ssT2*. Results: While both approaches showed many similarities, there were also differences. Compared to ssT2*, aT2* < 20 ms showed lower T2* and volume of IMH in patients and animals independent of MI age (all p < 0.005). While T2* determined from both methods were highly correlated against [Fe]Hemo (R2 = 0.9 for both), the slope of the regression curve for ssT2* was significantly larger as compared to aT2* < 20 ms (0.46 vs. 0.32, p < 0.01). Further, slightly larger absolute T2* cut-offs (patients: 23 ms; animals: 25 ms) showed similar IMH characteristics compared to ssT2*. Conclusion: Current quantification methods have excellent capacity to identify IMH, albeit the T2*of IMH and volume of IMH based on aT2* < 20 ms are smaller compared to ssT2*. Thus the method used to quantify IMH from T2* CMR may influence the diagnosis for IMH. | |
dc.eprint.version | Final published version | |
dc.identifier.citation | Chen Y, Ren D, Guan X, et al. Quantification of myocardial hemorrhage using T2* cardiovascular magnetic resonance at 1.5T with ex-vivo validation [published correction appears in J Cardiovasc Magn Reson. 2022 Feb 7;24(1):11. doi: 10.1186/s12968-021-00821-5]. J Cardiovasc Magn Reson. 2021;23(1):104. Published 2021 Sep 30. doi:10.1186/s12968-021-00779-4 | |
dc.identifier.uri | https://hdl.handle.net/1805/45323 | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | |
dc.relation.isversionof | 10.1186/s12968-021-00779-4 | |
dc.relation.journal | Journal of Cardiovascular Magnetic Resonance | |
dc.rights | Attribution 4.0 International | en |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.source | PMC | |
dc.subject | Myocardial infarction | |
dc.subject | Hemorrhage | |
dc.subject | Iron | |
dc.subject | Mass spectrometry | |
dc.title | Quantification of myocardial hemorrhage using T2* cardiovascular magnetic resonance at 1.5T with ex-vivo validation | |
dc.type | Article |